Sort   by:  
 Page size 
UnknownCD22 CAR T cells demonstrate high response rates and safety in pediatric and adult B-ALL: Phase 1b results.
Not available
S-EPMC12740236 | biostudies-literature
UnknownATM-dependent MiR-335 targets CtIP and modulates the DNA damage response.
Not available
S-EPMC3656122 | biostudies-literature
UnknownFunctional characterization and targeted correction of ATM mutations identified in Japanese patients with ataxia-telangiectasia.
Not available
S-EPMC3261637 | biostudies-literature
UnknownNon-viral chimeric antigen receptor (CAR) T cells going viral.
Not available
S-EPMC10139995 | biostudies-literature
UnknownUBE3A Regulates Synaptic Plasticity and Learning and Memory by Controlling SK2 Channel Endocytosis.
Not available
S-EPMC4520703 | biostudies-literature
UnknownNonsense Variant PRDM16-Q187X Causes Impaired Myocardial Development and TGF-β Signaling Resulting in Noncompaction Cardiomyopathy in Humans and Mice.
Not available
S-EPMC10752244 | biostudies-literature
Unknownc-JUN enhances CRISPR knockin anti-B7-H3 CAR T cell function in small cell lung cancer and thoracic SMARCA4-deficient undifferentiated tumors.
Not available
S-EPMC12866126 | biostudies-literature
UnknownEffects of an Initial Anti-CD19 CAR T-cell Therapy on Subsequent Anti-CD22 CAR T-cell Manufacturing and Clinical Outcomes in Patients with Relapsed/Refractory LBCL.
Not available
S-EPMC11964843 | biostudies-literature
UnknownIntravenous and intracranial GD2-CAR T cells for H3K27M<sup>+</sup> diffuse midline gliomas.
Not available
S-EPMC11735388 | biostudies-literature
UnknownCD22-directed CAR T-cell therapy for large B-cell lymphomas progressing after CD19-directed CAR T-cell therapy: a dose-finding phase 1 study.
Not available
S-EPMC11329226 | biostudies-literature
Sort   by:  
 Page size